Liver disease, aminoglycoside antibiotics and renal dysfunction
Author:
Open Access
- 1 July 1988
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 8 (4) , 966-968
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosisHepatology, 1988
- Studies of Risk Factors for Aminoglycoside NephrotoxicityAmerican Journal of Kidney Diseases, 1986
- Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosidesThe American Journal of Medicine, 1986
- A Model for Predicting Nephrotoxicity in Patients Treated with AminoglycosidesThe Journal of Infectious Diseases, 1986
- Cefotaxime Is More Effective Than Is Ampicillin–Tobramycin in Cirrhotics With Severe InfectionsHepatology, 1985
- Risk Factors for Nephrotoxicity in Patients Treated with AminoglycosidesAnnals of Internal Medicine, 1984
- Interaction between the renal excretion rates of β2-microglobulin and tobramycin in manClinica Chimica Acta, 1984
- Risk Factors for the Development of Auditory Toxicity in Patients Receiving AminoglycosidesThe Journal of Infectious Diseases, 1984
- Double-Blind Comparison of the Nephrotoxicity and Auditory Toxicity of Gentamicin and TobramycinNew England Journal of Medicine, 1980
- CEPHALOTHIN PLUS AN AMINOGLYCOSIDE IS MORE NEPHROTOXIC THAN METHICILLIN PLUS AN AMINOGLYCOSIDEThe Lancet, 1978